Status:
RECRUITING
Measurement Properties in People with Hemophilia
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
ETH Zurich
Conditions:
Hemophilia a
Hemophilia B
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this project is to determine the measurement properties (namely reliability and validity) of a set of clinical assessments, measuring different aspects of physical function.
Detailed Description
The medical treatment of hemophilia has advanced greatly in recent years. There are now medications that reduce the physical symptoms of hemophilia. Nevertheless, those affected by hemophilia suffer f...
Eligibility Criteria
Inclusion
- Diagnosed Hemophilia Types A or B
- Adult people ≥ 18 years
- Patients on prophylactic factor or non-factor replacement treatment, or on demand factor replacement treatment.
- Able to walk for 20 meters independently, with or without walking aid
- Signed informed consent to participate in the study
Exclusion
- Severe health conditions like severe cardiovascular, pulmonary, neurological or musculoskeletal diseases.
- Unable to perform the assessments due to disability or language problems.
Key Trial Info
Start Date :
October 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06565481
Start Date
October 31 2024
End Date
May 31 2026
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruud Knols
Zurich, Switzerland, 8091